News
Current position:Product Center > Antibodies > Biosimilar Antibodies > Anti-H_ERBB3(HER3) hIgG1 Antibody(Barecetamab)
Anti-H_ERBB3(HER3) hIgG1 Antibody(Barecetamab)
Product info

Cat.No:GM-28858AB

ProductAnti-H_ERBB3(HER3) hIgG1 Antibody(Barecetamab)



Cat. No. & Size

GM-28858AB-10      10 μg

GM-28858AB-100    100 μg

GM-28858AB-1000  1 mg





Description️

Species Reactivity      Human; Mouse; Cynomolgus

Clone                          Barecetamab

Source/Isotype          Monoclonal human IgG1/λ

Application                Flow cytometry

Specificity                  Detects ERBB3

Gene                           ERBB3

Other Names             ErbB-3, FERLK, LCCS2, MDA-BF-1, VSCN1, c-erbB-3, c-erbB3, erbB3-S, p180-ErbB3, p45-sErbB3, p85-sErbB3

Gene ID                      2065(human), 13867(mouse), 102115998(cynomolgus)

Background               Receptor tyrosine-protein kinase erbB-3, also known as HER3 (human epidermal growth factor receptor 3), is a membrane bound protein that in humans is encoded by the ERBB3 gene. During human development, ERBB3 is expressed in skin, bone, muscle, nervous system, heart, lungs, and intestinal epithelium.ERBB3 is expressed in normal adult human gastrointestinal tract, reproductive system, skin, nervous system, urinary tract, and endocrine system. ErbB3 is associated with targeted therapeutic resistance in numerous cancers including resistance to: HER2 inhibitors in HER2+ breast cancers; anti-estrogen therapy in ER+ breast cancers; EGFR inhibitors in lung and head and neck cancers; hormones in prostate cancers IGF1R inhibitors in hepatomas; BRAF inhibitors in melanoma. ErbB2 overexpression may promote the formation of active heterodimers with ErbB3 and other ErbB family members without the need for ligand binding, resulting in weak but constitutive signaling activity.

Storage                       Store at 2-8℃ short term (1-2 weeks).Store at ≤ -20℃ long term. Avoid repeated freeze-thaw.

Formulation               Phosphate-buffered solution, pH 7.2.

Endotoxin                  < 1 EU/mg, determined by LAL gel clotting assay




Data




/ueditor/image/20240514/1715654315457249/776dc64697e9b621a4e25e9379ee7e0a.png

/ueditor/image/20240514/1715654315720273/6e6574c374e3e8b6ccdbf5a6e49f4834.png

/ueditor/image/20240514/1715654315885268/7ca6d5715ea412bca62f69627596ff66.png


Current position:Product Center > -- > Anti-H_ERBB3(HER3) hIgG1 Antibody(Barecetamab)
classify
Anti-H_ERBB3(HER3) hIgG1 Antibody(Barecetamab)
Product info

Cat.No:GM-28858AB

ProductAnti-H_ERBB3(HER3) hIgG1 Antibody(Barecetamab)



Cat. No. & Size

GM-28858AB-10      10 μg

GM-28858AB-100    100 μg

GM-28858AB-1000  1 mg





Description️

Species Reactivity      Human; Mouse; Cynomolgus

Clone                          Barecetamab

Source/Isotype          Monoclonal human IgG1/λ

Application                Flow cytometry

Specificity                  Detects ERBB3

Gene                           ERBB3

Other Names             ErbB-3, FERLK, LCCS2, MDA-BF-1, VSCN1, c-erbB-3, c-erbB3, erbB3-S, p180-ErbB3, p45-sErbB3, p85-sErbB3

Gene ID                      2065(human), 13867(mouse), 102115998(cynomolgus)

Background               Receptor tyrosine-protein kinase erbB-3, also known as HER3 (human epidermal growth factor receptor 3), is a membrane bound protein that in humans is encoded by the ERBB3 gene. During human development, ERBB3 is expressed in skin, bone, muscle, nervous system, heart, lungs, and intestinal epithelium.ERBB3 is expressed in normal adult human gastrointestinal tract, reproductive system, skin, nervous system, urinary tract, and endocrine system. ErbB3 is associated with targeted therapeutic resistance in numerous cancers including resistance to: HER2 inhibitors in HER2+ breast cancers; anti-estrogen therapy in ER+ breast cancers; EGFR inhibitors in lung and head and neck cancers; hormones in prostate cancers IGF1R inhibitors in hepatomas; BRAF inhibitors in melanoma. ErbB2 overexpression may promote the formation of active heterodimers with ErbB3 and other ErbB family members without the need for ligand binding, resulting in weak but constitutive signaling activity.

Storage                       Store at 2-8℃ short term (1-2 weeks).Store at ≤ -20℃ long term. Avoid repeated freeze-thaw.

Formulation               Phosphate-buffered solution, pH 7.2.

Endotoxin                  < 1 EU/mg, determined by LAL gel clotting assay




Data




/ueditor/image/20240514/1715654315457249/776dc64697e9b621a4e25e9379ee7e0a.png

/ueditor/image/20240514/1715654315720273/6e6574c374e3e8b6ccdbf5a6e49f4834.png

/ueditor/image/20240514/1715654315885268/7ca6d5715ea412bca62f69627596ff66.png


Tel: 400-627-9288
Message consultation
reset
submit
Service
WhatApp
Phone
Message
Message consultation
reset
submit